Logotype for Sensirion Holding AG

Sensirion (SENS) H1 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sensirion Holding AG

H1 2024 earnings summary

23 Jan, 2026

Executive summary

  • H1 2024 revenue grew 3.9% year-over-year to CHF 128.0 million, with strong growth in automotive and industrial markets, while medical and consumer segments remained weak due to destocking and low demand.

  • Growth was driven by new automotive projects and industrial recovery, especially air purifiers and initial A2L sensor sales; medical and consumer segments were impacted by inventory corrections and economic headwinds.

  • Strategic focus on ramping up A2L gas leakage sensors for HVAC in the US, with product launches and ramp-ups planned for H2 2024, and optimizing productivity across operations and R&D.

  • Discontinuation of condition monitoring activities in Berlin (AiSight) executed as planned, with all extraordinary impairment and restructuring costs fully recognized in H1 2024.

  • Management changes include a new CFO and VP Sales to take office in H2 2024.

Financial highlights

  • Revenue increased 3.9% year-over-year to CHF 128.0 million (8.9% organic growth in local currency), with a -5.0% FX impact.

  • Adjusted gross margin was 47.5% (down from 56.3% in H1 2023) due to underutilization, product mix, and lower-margin modules.

  • Adjusted EBITDA was CHF 5.9 million (4.6% margin), with reported EBITDA impacted by CHF 28.6 million in extraordinary impairments from the Berlin closure.

  • Net loss was CHF -2.6 million adjusted (CHF -36.0 million reported) after extraordinary items; adjusted EBIT was CHF -2.8 million.

  • Operating cash flow was CHF 7.2 million, but free cash flow was negative at CHF -15.5 million due to high investments and CapEx.

Outlook and guidance

  • Full-year 2024 guidance confirmed: revenue target CHF 250–280 million (7–20% organic growth at constant FX), adjusted gross margin 47–49%, and adjusted EBITDA margin 5–10%.

  • H2 2024 growth expected from automotive modules and A2L gas leakage sensor ramp-up; air purifier recovery to level off.

  • Medical destocking expected to persist through year-end; visibility for 2025 remains low.

  • 2024 remains a transition year for profitability due to product mix and underutilization.

  • Medium-term outlook positive, supported by structural megatrends in the sensor market.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more